[Clinical study on reduction of postpartum bleeding by methyl carprost suppository]

Area of Science:

• Obstetrics and Gynecology
• Pharmacology

Background:

• Postpartum hemorrhage (PPH) remains a leading cause of maternal mortality worldwide.
• Oxytocin is a standard uterotonic, but its effectiveness can be limited, and it requires specific administration routes.

Purpose of the Study:

• To evaluate the efficacy of methyl carprost suppositories in controlling postpartum bleeding.
• To compare the effectiveness of methyl carprost administered vaginally versus rectally.

Main Methods:

• A randomized controlled trial involving 360 parturients.
• Study group received methyl carprost suppositories (vaginal or rectal).
• Control group received oxytocin (intramuscular or intravenous).

Main Results:

• Methyl carprost significantly reduced postpartum bleeding (mean 134.2-146.4 ml) compared to oxytocin (mean 210.6-267.9 ml) (P < 0.01).
• No significant difference in bleeding reduction between vaginal and rectal methyl carprost administration (P > 0.05).

Conclusions:

• Methyl carprost suppositories are more effective than oxytocin in managing postpartum bleeding.
• Rectal administration of methyl carprost is simple and suitable for resource-limited settings.